Clinical Trial Update: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral vancomycin for primary sclerosing cholangitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• oral vancomycin (vancomycin)

Snippet

Sponsor: Stanford University | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-21